Jaguar Health (JAGX) Finished Goods (2018 - 2026)

Jaguar Health (JAGX) has 9 years of Finished Goods data on file, last reported at $856000.0 in Q1 2026.

• Finished Goods for Q1 2026 came in at $856000.0, down 9.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $856000.0 (down 9.8% YoY), and the FY2025 annual result was $1.3 million, up 21.51% from the prior year.
• Finished Goods eased to $856000.0 in Q1 2026 per JAGX's latest filing, from $1.3 million in the prior quarter.
• Over five years, Finished Goods peaked at $1.7 million in Q2 2022 and troughed at $615000.0 in Q4 2023.
• A 5-year average of $1.0 million and a median of $949000.0 in 2025 frame the typical range for Finished Goods.
• The sharpest annual moves came in 2023 and 2024: Finished Goods tumbled 53.55% in 2023, then soared 76.91% in 2024.
• A 5-year view of Finished Goods shows it stood at $1.3 million in 2022, then plunged by 53.55% to $615000.0 in 2023, then soared by 76.91% to $1.1 million in 2024, then gained by 21.51% to $1.3 million in 2025, then plunged by 35.25% to $856000.0 in 2026.
• Business Quant data shows JAGX's Finished Goods at $856000.0 in Q1 2026, $1.3 million in Q4 2025, and $1.2 million in Q3 2025.